Is concomitant treatment with steroids and radiotherapy more favorable than sequential treatment in moderate-to-severe graves orbitopathy?
- 23 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in La radiologia medica
- Vol. 126 (2), 334-342
- https://doi.org/10.1007/s11547-020-01244-5
Abstract
Purpose Glucocorticoids (GCs) and external radiotherapy (RT) are used for treating moderate-to-severe Graves’ orbitopathy (GO). We aimed to assess whether GCs and RT were more effective when administered concomitantly or sequentially. Methods We retrospectively analyzed clinical outcomes [assessed by Clinical Activity Score (CAS) and NOSPECS classification] in 73 patients treated with both i.v. GCs and RT. The patients were divided in two groups: In group A (53 patients), RT was delivered concomitantly with GCs, and in group B (20 patients) RT was administered subsequently to the end of methylprednisolone. Results At baseline, CAS (median 4.0) and the percentage of patients encompassing the various grades of the classes 2, 3 and 4 of the NOSPECS score were similar in both groups. Six months after RT, CAS decreased to 2 in both groups (p = 0.0003 vs baseline) as well as NOSPECS class 4 (p < 0.0001 vs baseline). NOSPECS class 2 improved more in group A than in group B (p = 0.016). The median cumulative dose of GCs was lower in group A than in group B (median 4.500 vs 6000 mg, p < 0.007); the overall length of therapy was shorter in group A than in group B (68 vs 106 days, p < 0,02). The most common acute adverse effect was transient conjunctivitis (five in group A and three in group B); seven patients (five in group A and two in group B, age between 60 and 66 years) developed cataract, requiring surgery in five cases. Conclusions Concomitant administration of GC and RT showed a favorable effect in moderate-to-severe GO, thus suggesting that RT should be carried out early during steroid therapy, when clinical symptoms do not improve or deteriorate after the first i.v. administrations of GCs.Keywords
This publication has 33 references indexed in Scilit:
- Clinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgeryRadiation Oncology, 2012
- Treatment of mild, moderate-to-severe and very severe Graves’ orbitopathyBest Practice & Research Clinical Endocrinology & Metabolism, 2012
- The Efficacy of Radiation Therapy in the Treatment of Graves’ OrbitopathyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Outcome of thyroid associated ophthalmopathy treated by radiation therapyRadiation Oncology, 2011
- Radiotherapy in the treatment of Graves ophthalmopathy—to do it or not?Journal of Ocular Biology, Diseases, and Informatics, 2009
- Graves' OphthalmopathyThe New England Journal of Medicine, 2009
- Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GOActa Endocrinologica, 2008
- Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up studyOphthalmology, 2004
- Long-term results of irradiation for patients with progressive GRAVES’ ophthalmopathyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathyThe Lancet, 1993